+
IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation
ECONOMY & POLICY

IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages.

The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals.

Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”.

Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”.

Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.”

Image Source:https://www.msn.com/

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages. The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals. Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”. Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”. Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.” Image Source:https://www.msn.com/

Next Story
Infrastructure Urban

Lucknow To Get Modern Integrated Bus Terminal

The Uttar Pradesh cabinet has approved the development of an Integrated City Bus Terminal and Commercial Zone at the P4 Parking site in Vrindavan Yojna, Lucknow. The project promises to deliver a state-of-the-art facility aimed at improving public transport, easing congestion, and enhancing commuter convenience.Spread over 28,56,728 square feet (7.06 acres), the terminal will be developed on a design, build, finance, operate, and transfer (DBFOT) basis through a public-private partnership (PPP) model. The land, acquired from the Awas Vikas Parishad for Rs 1.5 billion, will be leased to a priva..

Next Story
Infrastructure Urban

Delhi Seeks Pause on Fuel Ban for Overage Vehicles

Delhi Chief Minister Rekha Gupta on Thursday said her administration is committed to long term, clean and sustainable transport solutions, after requesting the Centre’s air quality panel to suspend the sudden fuel ban on end of life vehicles.In a letter to Commission for Air Quality Management (CAQM) chairman Rajesh Verma, Environment Minister Manjinder Singh Sirsa argued that enforcing the ban is unfeasible due to technological constraints. The appeal comes three days after fuel stations stopped serving overage vehicles in the capital.“Faced with the hardships caused to Delh..

Next Story
Infrastructure Urban

Bengal Plans 350 CNG, 25 Electric Buses for Green Fleet

In a major push towards sustainable urban transport, the West Bengal Transport Department is preparing to procure around 350 compressed natural gas (CNG) buses, a senior official confirmed. Additionally, a proposal to acquire 25 electric buses is currently under consideration by the relevant authorities.Rejecting claims of phasing out electric buses due to high maintenance costs and limited battery life, the official clarified that the state remains committed to maintaining a balanced approach between both green alternatives.“There is no such plan to discontinue electric buses. On the contra..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?